Filter Results
Clinical Studies
Results filtered:Study status:
Open
Closed for Enrollment
Open
-
A Phase 3, Randomized, Open-label, Multicenter, Controlled Study To Evaluate The Efficacy And Safety Of Zanidatamab In Combination With Physician’s Choice Chemotherapy Compared To Trastuzumab In Combination With Physician’s Choice Chemotherapy For The Treatment Of Participants With Metastatic HER2-positive Breast Cancer Who Have Progressed On, Or Are Intolerant To, Previous Trastuzumab Deruxtecan Treatment
Scottsdale/Phoenix, AZ
Jacksonville, FL
Rochester, MN
The purpose of this study is to compare the efficacy of zanidatamab plus chemotherapy versus trastuzumab plus chemotherapy.
-
Harnessing E-Mindfulness Approaches For Living After Breast Cancer-HEAL-ABC
Scottsdale/Phoenix, AZ
Eau Claire, WI
Jacksonville, FL
La Crosse, WI
Mankato, MN
Rochester, MN
NRG-CC015 is a prospective, randomized phase III clinical trial to evaluate the efficacy of two distinct digital approaches for delivering a mindfulness-based intervention: a live, instructor-led version delivered over Zoom (MAPs LO), and an app-based, self-paced version (MAPs App). Participants will include younger breast cancer survivors (BCS) who were diagnosed with breast cancer at or before age 50 years, have completed their primary cancer treatment (i.e., surgery, radiation, and/or chemotherapy) at least 6 months earlier, and report elevated depressive symptoms.
.